🕵️ Myriad Genetics Inc ($MYGN)
SEC insider & ownership activity, last 12 months · CIK 899923 · every row links its SEC filing
Over the last 12 months insiders sold $67K against $722K of open-market buying. Phanstiel S. Louise bought $495K in discretionary trades (Feb). Blackrock, Inc. trimmed 15.3% → 8.5%. No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
3 buyers, $722K (5 lots) · 1 seller, $67K (1 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Phanstiel S. Louise | 3 | $495K | 0 | – | Feb 27, 2026 |
| Samraat S. Raha | 1 | $200K | 0 | – | Mar 9, 2026 |
| Kumar Rashmi | 0 | – | 1 | $67K | Jun 8, 2026 |
| Bisaro Paul | 1 | $28K | 0 | – | May 14, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Blackrock, Inc. | 8.5% | 13G | Apr 7, 2026 | filing ↗ | |
| Millennium Management LLC | 7.2% | 13G | Feb 11, 2026 | filing ↗ | |
| Millennium Group Management LLC | 7.2% | 13G | Feb 11, 2026 | filing ↗ | |
| Israel A. Englander | 7.2% | 13G | Feb 11, 2026 | filing ↗ | |
| Wellington Management Company LLP | 6.0% | 13G | Feb 10, 2025 | filing ↗ | |
| Integrated CORE Strategies (US) LLC | 5.6% | 13G | Feb 11, 2026 | filing ↗ | |
| Glenview Capital Management, LLC | 5.3% | 13G | Jan 13, 2026 | filing ↗ | |
| Robbins Larry | 5.3% | 13G | Jan 13, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Kumar Rashmi | $69K | Jun 8, 2026 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Officer/director changes (5.02) | Jun 17, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 4, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 4, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 4, 2026 | filing ↗ |
| Earnings (2.02) | May 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 5, 2026 | filing ↗ |
| Earnings (2.02) | Feb 23, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 23, 2026 | filing ↗ |
| Earnings (2.02) | Jan 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 12, 2026 | filing ↗ |
| Earnings (2.02) | Nov 3, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 3, 2025 | filing ↗ |
| Earnings (2.02) | Nov 3, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 3, 2025 | filing ↗ |
| Officer/director changes (5.02) | Oct 1, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 1, 2025 | filing ↗ |
| Officer/director changes (5.02) | Sep 29, 2025 | filing ↗ |
| Officer/director changes (5.02) | Aug 15, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 15, 2025 | filing ↗ |
| Earnings (2.02) | Aug 5, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 5, 2025 | filing ↗ |
| Material agreement (1.01) | Jul 31, 2025 | filing ↗ |
| New financial obligation (2.03) | Jul 31, 2025 | filing ↗ |
| Other events (8.01) | Jul 31, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 31, 2025 | filing ↗ |